







































Ghrelin and insulin are, respectively, orexigenic and 
anorexigenic hormones regulating feeding behavior [1-
3]. Furthermore, insulin and ghrelin regulate energy and 
glucose metabolism [4, 5]. Insulin and ghrelin are also 
implicated in learning/memory [6, 7], and insulin action 
is characteristically related to the Alzheimer disease [7]. 
All these functions are known to influence aging. In 
fact, insulin signaling regulates longevity, and ghrelin 
could promote longevity and serve as an anti-aging 
hormone [4, 8, 9, 10, 11]. These observations suggest 
that insulin, ghrelin and their interaction play an 










































Prior to meal intake, plasma ghrelin level is elevated 
and plasma insulin level is low, while following meal 
intake, plasma ghrelin level decreases and plasma 
insulin level increases [12]. Accordingly, dramatic 
reciprocal changes of these hormone levels are 
produced, possibly contributing to initiation and 
termination of feeding behavior. Thus, ghrelin and 
insulin are reciprocally regulated at the level of release. 
In addition, we hypothesized that ghrelin and insulin 
could act reciprocally on the target neuron in the 
feeding center, to further promote the interplay of the 
two hormones in regulating feeding.  
 
A large majority of neuropeptide Y (NPY) neurons in 
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(GHS-R) [13], and ghrelin directly interacts with and 
increases cytosolic Ca
2+ concentration ([Ca
2+]i) in the 
NPY neurons isolated from ARC [14]. It was shown 
that ghrelin also increases food intake via vagal 
afferent-mediated neural transmission to NPY neurons 
in ARC [15]. Thus, the principal mediator of orexigenic 
action of ghrelin is the ARC NPY neuron. On the other 
hand, anorexigenic effect of insulin could also involve 
the hyothalamic NPY. Inhibition of insulin receptor 
expression in the hypothalamus causes hyperphagia and 
increases fat mass [16]. Intracerebroventricular (ICV) 
injection of insulin inhibits the fasting-induced 
expression of NPY mRNA in the hypothalamus [17]. 
Insulin deficient type 1 diabetes exhibits increased 
expression of NPY and hyperphagia [18]. These reports 
suggest that the anorexigenic effect of insulin is 
mediated by inhibition of NPY neurons in the 
hypothalamus. However, direct effect of insulin on the 
ARC NPY neurons has not been evidenced. In the 
present study, we aimed to determine whether insulin 
directly interacts with ARC NPY neurons and 
counteracts the stimulatory action of ghrelin. We 
isolated single neurons from the ARC of rats aged 6 
weeks when the feeding function largely matures, 
measured [Ca
2+]i to monitor the neuronal activity, and 
observed direct effects of ghrelin and insulin on [Ca
2+]i. 
Localization of the insulin receptor in NPY neurons of 




Insulin suppresses ghrelin-induced [Ca
2+]i increases 
in isolated ARC neurons 
 
To determine the direct effect of insulin on NPY 
neurons, we used a method of the [Ca
2+]i  imaging in 
isolated single neurons followed by immuno-
cytochemical identification of NPY neurons [14,19]. 
Administration of 10
-10 M ghrelin increased [Ca
2+]i in 
the neurons isolated from ARC, confirming previous 
reports [14,19]. The ghrelin-induced [Ca
2+]i  increase 
was markedly suppressed by administration of 10
-12 M 
insulin (Figure 1A, left panel) in a neuron that was 
subsequently shown to contain NPY (Figure 1A, right 
panel). The majority (14 of 19, 74%) of the ghrelin-
activated insulin-inhibited neurons were NPY neurons 
(Figure 1B). Insulin exerted this effect in a 




-12 M, and 10
-10 M suppressed ghrelin-induced 
[Ca
2+]i increase in 6 of 23 (26%), 7 of 17 (41%), 21 of 
34 (62%), and 16 of 30 (53%) ghrelin-responsive 
neurons, respectively (Figure 1C). Percent reduction of 
amplitude of ghrelin-induced [Ca
2+]i increase by insulin 





-10 M, respectively (Figure 1D). 
Thus, insulin at 10
-12 M exerted a maximal effect. 
 
Localization of insulin receptor in NPY neurons of 
ARC 
 
Double-fluorescence immunohistochemistry showed 
that the neurons expressing NPY and those expressing 
insulin receptor were abundantly distributed in the ARC 
of rat hypothalamic section (Figure 2, A-B). A large 
majority (85%) of NPY neurons expressed insulin 




Insulin plays an important role in the central regulation 
of feeding and metabolism [3, 16], including its action 
via the hypothalamus to suppress hepatic glucose 
production [20]. Insulin enters the brain through the 
blood-brain barrier (BBB) [21]. However, the target 
neurons of insulin in the hypothalamus have not been 
fully clarified. ARC is considered the first order center 
that senses peripheral signals including hormones. 
Insulin deficient type 1 diabetes exhibits hyperphagia 
and is associated with increased expression of NPY in 
ARC [18]. Furthermore, type 2 diabetic Goto-Kakizaki 
(GK) rats with impaired insulin secretion and action 
also show hyperphagia and increased expression of 
NPY in ARC [22]. Hence, the ARC NPY neuron has 
been suggested as a candidate target for anorexigenic 
action of insulin. The present study demonstrated that 
insulin directly interacts with ARC NPY neurons and 
counteracts the ghrelin action to increase [Ca
2+]i. Since 
the ghrelin-induced [Ca
2+]i  increase in ARC NPY 
neurons is coupled to stimulation of food intake [19], 
the insulin action to counteract ghrelin in ARC NPY 
neurons is suggested to be linked to inhibition of 
feeding. Regarding the insulin antagonism against 
ghrelin, insulin reportedly decreases preproghrelin 
mRNA expression in proGhrelin-expressing mHypoE-
38 neuronal cell line [23].  
 
It has been reported that the plasma insulin 
concentration increases to a level around 5x10
-10 M after 
meals [12], and that the peripheral insulin enters the 
brain through BBB at a rate of 0.046 % [21]. From 
these reports, the insulin concentration in the brain after 
meals is estimated to be in a range of 10
-13 M ~10
-12 M. 
In the present study, 10
-12 M insulin exerted a maximal 
effect on NPY neurons. Therefore, it is suggested that 
the inhibition of NPY neurons by insulin takes place 
most effectively following ingestion of food.  
 
Ghrelin is the only one orexigenic hormone of the 
peripheral origin, whose plasma level is high before 
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anorexigenic insulin is low before meals and rises after 
meals. Thus, the plasma levels of these hormones 
change in a reciprocal manner. As an underlying 
mechanism, ghrelin inhibits insulin release from 
pancreatic islets [5, 24]. In addition to the reciprocal 
















































monstrated that these hormones reciprocally regulate 
their common target, ARC NPY neurons. It is suggested 
that at postprandial states, decreased ghrelin level, 
increased insulin level, and insulin action to counteract 
ghrelin-induced activation of NPY neurons work in 
concert to effectively inhibit the NPY neuron activity 





















































‐10  M  ghrelin  increased  [Ca
2+]i  and  administration  of  10

































We previously reported that leptin also suppresses 10
-10 
M ghrelin-induced [Ca
2+]i  increases in ARC NPY 
neurons in a concentration-dependent manner showing a 
maximal effect with 10
-12 M leptin [19]. The estimated 
physiological concentration of leptin in the brain is 
around 10
-12 M [19, 21]. Our present and previous data 
suggest that postprandial concentrations of insulin and 
leptin in the brain exert most efficient suppression of 
ARC NPY neurons, contributing to production of 
satiety.  
 
In summary, this study demonstrates that insulin directly 
interacts with ARC NPY neurons and attenuates ghrelin-
induced activation of ARC NPY neurons. It is suggested 
that postprandial increase in plasma insulin/ghrelin ratio 
and insulin inhibition of ghrelin action in ARC NPY 
neurons cooperate to effectively inhibit the neuron 




Animals. Male Sprague-Dawley rats aged 6 weeks were 
used in the experiments. Animals were maintained on a 
12-h light/dark cycle and given conventional food and 
water ad libitum. Experimental procedures and care of 
animals were carried out according to the Jichi Medical 
School Institute of Animal Care and Use Committee. 
 
Preparation of single neurons from ARC. Single 
neurons were prepared from the ARC following 
previous reports [14, 25]. Briefly, the whole ARC was 
dissected out and incubated with 20 units/ml papain 
(Sigma Chemical, St. Louis, MO), 1 mM cystein, 0.015 






















min at 36 ˚C. The single neurons obtained were 
distributed onto coverslips and incubated in the 




2+]i and criteria for [Ca
2+]i 
responses in single ARC neurons. [Ca
2+]i  was 
measured by radiometric fura-2 fluorescence imaging 
as previously reported [14, 26]. Briefly, single neurons 
on coverslips were incubated with 2 µmol/l fura-2/AM 
(Dojin chemical, Kumamoto, Japan) for 1 h at room 
temperature, mounted in chamber and superfused with 
HKRB at 1 ml/min at 33 °C. Fluorescence images due 
to excitation at 340 and 380 nm were captured and the 
ratio (F340/F380) images produced by an Argus-50 
system (Hamamatsu Photonics, Hamamatsu, Japan).  
 
When changes in ratio (F340/F380) took place within 5 
min after administration of reagents and their 
amplitudes were more than 0.5 ratio unit, they were 
considered the responses. Regarding the suppression of 
ghrelin response by insulin, when insulin decreased the 
ghrelin-induced [Ca
2+]i increase by 40% or greater, it 
was considered the suppression.  
 
Immunocytochemistry for NPY in single neurons. 
Immunocytochemistry of NPY neurons were carried out 
as previously reported [14, 19]. Rabbit anti-NPY 
antibody (Diasorin, Srillwater, MN, 1:10000) was used 
for NPY staining. Correlation of [Ca
2+]i  and 
immunocytochemical data were performed by 
comparing the images of the phase-contact photographs 
of the cells subject to [Ca
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receptor in ARC. Colchicine (0.2 mg/ 15 µl) was ICV 
injected 1 day before the perfusion. Rat brains were 
perfused with 4 % parformaldehyde and embedded in 
paraffin wax. Five µm coronal sections of brain 
between -1.78 and -2.45 mm from bregma based on the 
structure of the Brain Maps [27] were cut using a 
microtome. To retrieve antigenicity, sections were 
heated by autoclave in 10 mM citrate buffer for 20 min 
[28]. Sections were immunostained according to 
standard procedures [26, 28]. Mouse monoclonal 
antibody against insulin receptor β-subunit 
(CHEMICON, CA, 1:100) and rabbit anti-NPY 
antibody (Diasorin, Srillwater, MN, 1:10000) were used 
as primary antibodies, and Alexa 488 labeled anti-
mouse IgG and Alexa 594 labeled anti-rabbit IgG 
(Molecular probes CA, 1:500) were used as secondary 
antibodies, respectively. Fluorescence images were 
acquired with Olympus BX50 fluorescence microscope. 
 
Solution and chemicals. Measurements were carried out 
in HKRB solution composed of 129 mmol/l NaCl, 5.0 
mmol/l NaHCO3, 4.7 mmol/l KCl, 1.2 mmol/KH2PO4, 
1.8 mmol/l CaCl2, 1.2 mmol/l MgSO4, and 10 mmol/l 
HEPES at pH 7.4. Ghrelin (rat) and insulin (porcine) 
were purchased from Peptides Institute (Osaka, Japan) 
and Sigma (Tokyo, Japan), respectively. 
 
Statistical analysis.  One-way ANOVA followed by 
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